SPKEL receives EAC GMP Approval (15 October, 2025)
We are pleased to announce that our manufacturing facility in Kenya — SQUARE PHARMACEUTICALS KENYA EPZ LTD — has received GMP (Good Manufacturing Practice) approval from the East African Medicines Regulatory Harmonization (EAC-MRH) Authority on 15 October, 2025.
This certification under the EAC GMP Harmonization framework ensures that our operations meet the unified quality, safety, and efficacy standards recognized across the eight EAC member states — Burundi, the Democratic Republic of Congo, Kenya, Rwanda, Somalia, South Sudan, Tanzania, and Uganda.
This milestone reaffirms SQUARE’s unwavering commitment to global quality standards, regulatory compliance, and sustainable healthcare solutions — strengthening our capability to serve partners and patients across East Africa and beyond.
This certification under the EAC GMP Harmonization framework ensures that our operations meet the unified quality, safety, and efficacy standards recognized across the eight EAC member states — Burundi, the Democratic Republic of Congo, Kenya, Rwanda, Somalia, South Sudan, Tanzania, and Uganda.
This milestone reaffirms SQUARE’s unwavering commitment to global quality standards, regulatory compliance, and sustainable healthcare solutions — strengthening our capability to serve partners and patients across East Africa and beyond.
